The aim of this review was to identify factors that influence patients' adherence to anti-
osteoporotic therapy. Factors identified that were associated with poorer medication …

Objectives This study examined patient adherence and persistence to oral bisphosphonates
for the treatment of osteoporosis in real-world settings. Methods A systematic review was …

Different molecular subtypes of glioblastoma (GBM) have been recently identified, of which
the mesenchymal subtype is associated with worst prognoses. Here, we report that …

Many patients at increased risk of fractures do not take their medication appropriately,
resulting in a substantial decrease in the benefits of drug therapy. Improving medication …

The objectives of this study were to estimate persistence with denosumab and put these
results in context by conducting a review of persistence with oral bisphosphonates …

BACKGROUND: Community pharmacies provide a promising platform for monitoring and
improving therapy adherence and providing pharmaceutical care. Structured methods and …

Adherence to anti-osteoporosis medications is poor. We carried out a cohort study using a
real-world population database to estimate the persistence of anti-osteoporosis drugs …

Objective: A well-recognized gap exists between evidence-based recommendations for post-
fracture care and actual clinical practice, demonstrated by the high percentage of fragility …

Background Given the health and economic burden of fractures related to osteoporosis,
suboptimal adherence to medication and the increasing importance of shared-decision …

BACKGROUND: Prior research has shown that rates of persistence and compliance with
osteoporosis therapies are associated with significantly fewer vertebral, nonvertebral, and …